tranexamic acid

This page contains recent news articles, when available, and an overview of tranexamic acid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Xanodyne Achieves Positive Efficacy Results in Pivotal Phase 3 ...  -  Aug 5, 2008
In addition to these two recently completed Phase 3 clinical trials, which evaluated the efficacy and safety of tranexamic acid MR, two additional Earthtimes (press release),

Tranexamic acid does not seem to lower rebleed rate in pediatric ...  -  Jul 25, 2008
Treating children with traumatic hyphema with tranexamic acid plus topical steroids does not appear to significantly lower the incidence of rebleed compared OSN SuperSite (subscription),

Xanodyne sees good trial results for menorrhagia treatment  -  Aug 5, 2008
The trials for the tranexamic acid modified-release formulation evaluated its effectiveness and safety, according to a news release. Bizjournals.com,

XenoPort Inc.Q2 2008 Earnings Call Transcript  -  Aug 6, 2008
This is in addition to double digit royalties on future US sales of XP21510, our Transported Prodrug of tranexamic acid, if approved by FDA in the future. Seeking Alpha,

Trasylol: Proof That Preemption is Bad  -  Jul 3, 2008
Dr. Mangano recommended replacing aprotinin with tranexamic acid, another similar medication that he believed would save millions and provide a safer InjuryBoard.com,

Heavy periods (menorrhagia)  -  Jun 25, 2008
The good news is that treatment to reduce bleeding is very effective from medication such as tranexamic acid tablets and the contraceptive pill to surgery goodtoknow,

The heart surgery time bomb: one man's brush with death due to ...  -  Jun 16, 2008
The only brakes were financial - it cost £200 compared with tranexamic acid, the alternative (which cost £2). By 2004, Trasylol's sales were $213 million Daily Mail,

Anti-bleeding drug raises death risk — study  -  May 15, 2008
For every 100 patients getting tranexamic acid or aminocaproic acid, four died, according to the study, published electronically on Wednesday by the New TheChronicleHerald.ca,

A Comparison of Aprotinin and Lysine Analogues in High-Risk ...  -  May 28, 2008
We sought to determine whether aprotinin was superior to either tranexamic acid or aminocaproic acid in decreasing massive postoperative bleeding and other New England Journal of Medicine (subscription),

BART Closes the Book on Aprotinin  -  May 20, 2008
Compare the effect of aprotinin with tranexamic acid vs aminocaproic acid for preventing massive bleeding after high-risk cardiac surgery. Medscape (subscription)

Drug aprotinin boosts risk of death: study  -  May 14, 2008
..."Overall, our study supports the use of tranexamic acid or aminocaproic acid over aprotinin during high-risk heart surgery," stressed Dr. Paul Hebert, AFP

Breastfeeding May Prevent Arthritis, Antifibrinolytic Agents ...  -  May 14, 2008
...about 6% of patients who received aprotinin died within 30 days of surgery compared to 4% of patients who received tranexamic acid or aminocaproic acid. Insider Medicine,

It's Game Over for Trasylol, but Bayer Refuses to Fold  -  May 25, 2008
...patients using aprotinin (Trasylol) were more likely to die than patients administered alternatives--specifically, tranexamic acid or aminocaproic acid. Lawyers and Settlements

Guidelines for von Willebrand Disease Urge Routine Screening for ...  -  Apr 22, 2008
For women with menorrhagia, combined oral contraceptives, placement of a levonorgestrel intrauterine device, aminocaproic or tranexamic acid Journal of American Medical Association (subscription),

Myelosuppression: A Report from the 2007 ONS Annual Congress  -  Mar 31, 2008
...bloodless interventions, including cell salvage, aprotinin, colloids, growth factors, tranexamic acid, and the overlap autogenous tissue (OAT) patch. Cancer Consultants,

Suspended heart surgery drug linked to higher death risk, averse ...  -  Feb 20, 2008
...in high risk cardiac patients designed to compare the more expensive aprotinin to two cheaper drugs in the class, aminocaproic acid or tranexamic acid. The Canadian Press

Aprotinin Safe in On-Pump but Not Off-Pump CABG  -  Feb 13, 2008
They separately analyzed the incidence of renal dysfunction in patients receiving aprotinin, tranexamic acid, or no antifibrinolytic in the presence or Medscape (subscription)

Guidelines Issued for Diagnosis and Management of von Willebrand's ...  -  Mar 5, 2008
The antifibrinolytic drugs aminocaproic acid and tranexamic acid can also be used to treat mild mucocutaneous bleeding in VWD. Concentrates of VWF can be Medscape (subscription)

Bayer Drug Alleged to Have Led to 22000 Deaths  -  Feb 19, 2008
Trasylol was 20.8 percent, compared to 15.8 percent for those given another drug, aminocaproic acid, and 14.7 percent for those given tranexamic acid. Best Syndication,

LeftBlog: An ppen letter to Congressman Dr. Charles Boustany Jr.  -  Feb 19, 2008
Both of these medications Aminocaproic acid and Tranexamic acid respectively, act without the renal damage or the $1000 price tag of Trasylol. The Daily Advertiser,

FDA Fails - The Story of Joseph Randone  -  Feb 17, 2008
In contrast, the less expensive generic medications aminocaproic acid and tranexamic acid are safe alternatives." In the case of Trasylol, Bayer hired a InjuryBoard.com,

Vendors Tout Spa Category Advancements  -  Feb 28, 2008
Calif., addresses concerns about hydroquinone with its $60 Surface Bright product by replacing the controversial compound with tranexamic acid. Women's Wear Daily

Treatment without transfusions  -  Feb 1, 2008
They also use special surgical sealants and glues to control minor bleeding, and drugs such as tranexamic acid to help blood clot normally. Los Angeles Times,

Bayer pulls Leukine from US, positive Nexavar news in Japan  -  Jan 24, 2008
...a higher risk of death amongst those given Trasylol compared with two older antifibrinolytic agents, epsilon-aminocaproic acid and tranexamic acid. Pharma Times (subscription),

Need to Know - Contraception  -  Jan 29, 2008
There is little that can be done about this apart from perseverance or continuous use of NSAIDs or tranexamic acid if the bleeds are heavy. Pulse,

Sanjivani Paranteral expects huge orders for SANCIDAL  -  Jan 17, 2008
...ivimax, piptaz, cefepime, c-bactum, methylcoblamin and tranexamic acid. Some of its clients include Zydus Cadila, Alkem, and government hospitals. Myiris.com,

Aprotinin (Trasylol) Marketing Halted Over Suspected Mortality Risk  -  Nov 5, 2007
The researchers planned to enroll 3000 patients for randomization to aprotinin, epsilon-aminocaproic acid, or tranexamic acid. The 30-day mortality in the MedPage Today,

Bayer Trasylol study halted  -  Oct 30, 2007
...aminocaproic acid and tranexamic acid in approximately 3000 high-risk cardiac surgical patients undergoing either re-operation for coronary heart bypass Pharmaceutical Business Review

Excess Deaths Shut Down Aprotinin (Trasylol) Arm of Heart Surgery ...  -  Oct 26, 2007
The researchers planned to enroll 3000 Canadian patients for randomization to aprotinin, epsilon-aminocaproic acid, or tranexamic acid. MedPage Today,

FDA Issues an Early Communication about an Ongoing Safety Review ...  -  Oct 25, 2007
The preliminary findings suggest that, compared to the antifibrinolytic drugs, epsilon-aminocaproic acid and tranexamic acid, aprotinin increases the risk PharmaLive.com (press release),

Bayer halts sales of anti-bleeding drug after Canadian trial ...  -  Nov 5, 2007
...until the BART results were made public used aprotinin (Trasylol's generic name) in his surgeries but is now using an alternate drug, tranexamic acid. The Canadian Press

Trasylol (aprotinin) Trial Stopped Due to Adverse Effects  -  Oct 27, 2007
...in preventing excessive post-cardiac surgery bleeding, as compared to other antifibrinolytics, such as, epsilon-aminocaproic acid and tranexamic acid. MedHeadlines,

Local docs ponder use of pulled anti-bleeding drug  -  Nov 7, 2007
Two other drugs, aminocaproic acid and tranexamic acid, are also used to help stop excessive bleeding. Robinson said he doesn't use either drug "on a Newsday,

Heart surgery drug withdrawn worldwide  -  Nov 6, 2007
Apart from the lack of substantial health risks, other drugs such as aminocaproic acid and tranexamic acid are also far less expensive. Hindustan Times,

Bayer halts drug sales after study links it to risks  -  Nov 6, 2007
...of deaths among patients who received Trasylol than those who received the drugs it was being tested against, aminocaproic acid and tranexamic acid. Toronto Star,

Trasylol Pulled From Worldwide Market  -  Nov 5, 2007
Trasylol was 20.8 percent, compared to 15.8 percent for those given another drug, aminocaproic acid, and 14.7 percent for those given tranexamic acid. U.S. News & World Report,

Canadian trial prompts Bayer to halt marketing drug  -  Nov 5, 2007
It is a multi-centre randomized controlled trial to compare the efficacy and safety of aprotinin, aminocaproic acid and tranexamic acid. CTV.ca,

Old treatment could save new lives  -  Nov 2, 2007
Professor Ian Roberts, of the London School of Hygiene and Tropical Medicine - who is leading the two year study into the affects of tranexamic acid - said BBC News,

Canadian Trial Of Heart Surgery Drug Trasylol Halted  -  Oct 26, 2007
...appeared to be at a higher risk of death compared to patients treated with the other two antifibrinolytic drugs, aminocaproic acid and tranexamic acid. Medical News Today,

Loss Of Blood During Cardiac Surgeries Slashed By Antifibrinolytic ...  -  Oct 22, 2007
One of the effective drugs, tranexamic acid, is quite cheap and is likely to be cost effective, particularly in cardiac surgery. The big question is whether MedIndia,

Sale of heart Surgery Drug Suspended by Bayer  -  Nov 6, 2007
The BART trial which was the first to test aprotinin against other drugs tested it against tranexamic acid and aminocaproic acid, which are all used to stem Earthtimes,

Bayer Pulls Heart Surgery Drug Trasylol  -  Nov 6, 2007
...also linked with an increased risk of death due to all causes compared to patients on two other antifibrinolytics, aminocaproic acid or tranexamic acid. Medical News Today,

Bayer suspends sales of Trasylol on safety concerns  -  Nov 6, 2007
...findings indicated a higher risk of death compared to two antifibrinolytic drugs used in the study, epsilon-aminocaproic acid and tranexamic acid. Pharma Times (subscription),

Bayer pulls its anti-clotting drug 'Trasylol' from market  -  Nov 6, 2007
...epsilon-aminocaproic acid (10g loading dose + 2g/hr on CPB), or tranexamic acid (30mg/kg loading dose + 2mg/kg pump prime + 16mg/kg/hr on CPB). The Money Times,

Bayer yanks aprotinin off the market pending analysis of BART  -  Nov 5, 2007
...patients receiving aprotinin died within the first 30 days of the trial, as compared with patients taking epsilon-aminocaproic acid or tranexamic acid. TheHeart.Org,

Trasylol: AG Bayer Halts Global Sales of Troubled Drug  -  Nov 5, 2007
They were to be randomly assigned one of three drugs that were being used for comparison purposes: aprotinin, aminocaproic acid, and tranexamic acid. Lawyers and Settlements,

Bayer Temporarily Suspends Global Trasylol(R) Marketing  -  Nov 5, 2007
...for 30- day mortality) for patients in the aprotinin treatment arm compared to patients who received either aminocaproic acid or tranexamic acid. PR Newswire (press release),

Trial Examines Blood Conservation Using Antifibrinolytics  -  Nov 2, 2007
The three drugs examined, aminocaproic acid, aprotinin and tranexamic acid, were all approved by Health Canada and were not considered investigational. eMaxHealth.com,

FDA Indicates Trasylol May Increase Death Risk  -  Oct 29, 2007
Those drugs are epsilon-aminocaproic acid and tranexamic acid. It was determined that a continued enrollment of patients into the study would not change the Associated Content,

Bayer Halts Trials on Trasylol Used in Bypass Surgery  -  Oct 27, 2007
The aim of the trial, known by its acronym BART, is to compare the effectiveness and safety of aprotinin, aminocaproic acid and tranexamic acid — three MedIndia,

Bayer Trasylol trial halted due to high risk of death  -  Oct 26, 2007
The study was meant to determine if aprotinin is superior to other antifibrinolytic drugs such as epsilon-aminocaproic acid or tranexamic acid. Food Consumer,

Bayer's Trasylol back in the dock as Canadian study is stopped  -  Oct 26, 2007
...that Trasylol increases the risk of death compared to two antifibrinolytic drugs used in the study, epsilon-aminocaproic acid and tranexamic acid. Pharma Times (subscription),

Aprotinin-related mortality risk puts brakes on randomized surgery ...  -  Oct 25, 2007
BART had been designed to determine whether aprotinin would be better than either epsilon-aminocaproic acid or tranexamic acid in preventing "massive TheHeart.Org,

Xenoport Q3 2007 Earnings Call Transcript  -  Nov 7, 2007
510 is the Transported Prodrug of tranexamic acid, which has been approved in several countries in Europe for the treatment menorrhagia, or excessive Seeking Alpha,

Churchill Downs Q3 Profit Falls; Revenues Up 7.1% - Quick Facts [CHDN]  -  Nov 7, 2007
...xenoport is eligible to receive aggregate cash payments of up to $130.0 million and $5.0 million for XP21510 and XP12B, Xanodyne's Phase 3 tranexamic acid RTT News,

xenoport Reports Third Quarter Financial Results  -  Nov 7, 2007
...xenoport is eligible to receive aggregate cash payments of up to $130.0 million and $5.0 million for XP21510 and XP12B, Xanodyne’s Phase 3 tranexamic acid Business Wire (press release),

XenoPort and Xanodyne Announce Exclusive US Licensing Agreement ...  -  15 Oct 2007
We plan to develop XP21510, which is covered by an allowed US composition of matter patent, as a follow on product to Xanodyne’s Phase 3 tranexamic acid Business Wire (press release),

International Trauma Trial Could Save Thousands Of Lives, UK  -  Oct 4, 2007
Tranexamic acid is a treatment that may minimise bleeding by reducing clot breakdown. It is widely used in major surgery, as it is effective in reducing Medical News Today (press release),

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive] :

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.